Although several genomic and genetic aberrations, such as MYCN amplification, ALK mutation, PHOX2B mutation, and single nucleotide polymorphisms within LIN28B, have been found to be significantly associated with a poor outcome [4], further investigations on mechanisms driving NB progression are still warranted to provide insights for improving the prognosis of patients. Here, MYCN is linked to neuroblastoma.